ALICIA CALOS: Open Payments
NPI 1346875242 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 6 payments from 3 companies in 2025. Trend: 2023 $498 · 2024 $615 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 4 | $144 |
| Novo Nordisk Inc | 1 | $29 |
| Amgen Inc. | 1 | $16 |
Products named: ONPATTRO, Ozempic, REPATHA.
Industry payments across TX — which companies pay providers there.
